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ear Editor,
epatitis C virus (HCV) infection is a global health problem
nd  approximately 80% of the patients develop chronic hepati-
is  C, which can progress to liver cirrhosis and hepatocellular
arcinoma. HCV genotype is a classical predictor of the suc-
ess  of the standard treatment (interferon- in combination
ith ribavirin). HCV genotype 1 carriers have usually a lower
ate  of response than patients infected with HCV genotypes
 and 3.1 Human single nucleotide polymorphisms near the
ene  for interferon-3 (IFNL3; formerly known as IL28B) were
lso  recently associated with spontaneous HCV clearance and
ustained  response to interferon-based therapy.2 The present
tudy  aimed to determine the frequency of the HCV and IFNL3
enotypes  in hepatitis C patients from the North region of Rio
rande  do Sul state, Southern Brazil.
Adult individuals with chronic hepatitis C attended in
eferral  services for patient care in Passo Fundo (a medium-
ized  urban center in the North region of Rio Grande do
ul  state) were  selected from August 2010 to July 2011.
ocio-demographic data were obtained from a structured
uestionnaire and patient medical records were reviewed to
btain clinical and virological information. IFNL3-molecular
nalysis was  performed as previously described.2 The study
as  approved by the Research Ethics Committee of the Uni-
ersidade  Luterana do Brasil (ULBRA).A total of 191 HCV-infected patients were included in the
tudy.  Patients were  predominantly female (52.9%) and had
 mean age of 51.6 ± 11.4 years. Approximately half of theparticipants  (n = 92, 48.2%) received blood transfusions and 75
patients  (39.3%) reported that this condition was the possible
HCV  transmission route. Use of sharp objects (26.7%) and nee-
dle  sharing (17.8%) were also cited as possible transmission
factors. HCV genotype 1 was found in 76 (39.8%), genotype 2
in  46 (24.1%) and genotype 3 in 69 patients (36.1%). HCV geno-
type  1 was  signiﬁcantly more  often in users of illicit drugs,
while  genotype 2 was  more  frequently found in women and
old  people. Sixty patients (31.4%) showed the CC, 97 (50.8%) CT
and 34 (17.8%) TT IFNL3 genotypes (Table 1).
Some HCV genotypes have a restricted geographical distri-
bution  (genotypes 4-6), while others (genotypes 1-3) are more
broadly  disseminated. HCV genotype 1 is the most preva-
lent  in the world.1 In the present study, genotype 1 was  also
demonstrated in the highest frequency, followed by geno-
types  3 and 2, respectively. Other studies in Brazil have also
shown  the occurrence of these three genotypes, but geno-
type  1 with frequencies over 60%, while genotype 2 lower
than  10%.3,4 This unusual high frequency of HCV genotype
2  conﬁrms the results observed in a previous study.5 In the
present  report it was  further demonstrated the high propor-
tion  of old women infected with this genotype. IFNL3 CC
genotype,  a good human prognostic factor of treatment out-
come,  was also found in a percentage similar to other Brazilian
study.2In conclusion, the data obtained in the present study have
shown  a high frequency of HCV genotype 2 in an urban center
in  Southern Brazil and suggest the HCV genotypes could have
different  transmission routes.
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Table 1 – Distribution of socio-demographic and epidemiological characteristics in patients stratiﬁed according to HCV
genotypes.
Variable Total (n = 191) HCV genotypes
1 (n = 76) 2  (n = 46) 3  (n = 69) p
Male gender 90  (47.1) 42 (55.3) 15 (32.6) 33  (47.8) 0.052
Age (years) 51.6  ± 11.4 50.0 ± 10.0 55.6 ± 13.8 50.7 ± 10.6 0.024
Skin color 0.204
White 126 (66.0) 44 (57.9) 37 (80.4) 45 (65.2)
Mixed/mulatto 54 (28.2) 27 (35.5) 7 (15.2) 20 (28.9)
Black 11 (5.8) 5 (6.6) 2 (4.3) 4 (5.8)
Educational level 0.156
Complete primary education or less 97 (50.8) 33 (43.4) 23 (50.0) 41 (59.4)
Secondary or higher education 94 (49.2) 42 (56.6) 23 (50.0) 28 (40.6)
Possible forms of HCV infectiona 0.577
Sex 19 (9.9) 8 (10.6) 1 (2.2) 10 (14.5)
Blood transfusion 75 (39.3) 26 (34.2) 23 (47.8) 27 (39.1)
Infected material 51 (26.7) 19 (25.0) 15 (32.6) 17 (24.6)
Hemodialysis 2 (1.0) – 1 (2.2) 1 (1.4)
Sharing needles 34  (17.8) 19 (25.0) 5(10.9) 10 (14.5)
Occupational exposure 7 (3.7) 2 (2.6) 1 (2.2) 4 (5.8)
Smoking drug use 37 (19.4) 25 (32.9) 1 (2.2) 11 (15.9) <0.001
Snorting drug use 28 (14.7) 19 (25.0) 1 (2.2) 8 (11.6) 0.001
Injecting drug use 21 (11.0) 13 (17.1) 1 (2.2) 7 (10.1) 0.026
Blood transfusion 92 (48.2) 33 (43.4) 25 (54.3) 34 (49.3) 0.491
Hemodialysis 4 (2.1) 1 (1.3) 1 (2.2) 2 (2.9) 0.831
Tattoo 343(17.3) 18 (23.7) 6 (13.0) 9 (13.0) 0.163
Piercing 4 (2.1) – 1 (2.2) 3 (4.3) 0.129
IFNL3 – CC genotype 60 (31.4) 21 (27.6) 17 (37.0) 22 (31.9) 0.339
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